ALGEN — genOway SA Cashflow Statement
0.000.00%
- €35.72m
- €38.70m
- €20.05m
- 85
- 39
- 55
- 64
Annual cashflow statement for genOway SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | — |
Source: | Interim Report | ARS | ARS | ARS | |
Standards: | FAS | — | — | FAS | — |
Status: | Final | Final | Final | Final | fx Preliminary |
Net Income/Starting Line | -1.04 | -0.687 | -0.323 | 0.778 | — |
Depreciation | |||||
Non-Cash Items | -0.375 | -0.122 | -0.347 | -0.183 | — |
Other Non-Cash Items | |||||
Changes in Working Capital | -2.11 | -0.739 | -1.99 | -0.975 | — |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -2.19 | -0.164 | -0.561 | 2.36 | — |
Capital Expenditures | -1.14 | -4.52 | -2.28 | -1.92 | — |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.021 | -0.23 | 0.013 | -0.025 | — |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -1.12 | -4.75 | -2.26 | -1.94 | — |
Financing Cash Flow Items | — | 1.04 | 4.42 | 0 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1.35 | 6.54 | 5.71 | -1.14 | — |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1.97 | 1.63 | 2.89 | -0.727 | — |